Coeptis Therapeutics appoints CFO
BongkarnThanyakij
- Coeptis Therapeutics (NASDAQ:COEP) appointed Brian Cogley as CFO, effective immediately.
- Cogley succeeds Christine Sheehy, who will remain with Coeptis in a senior finance capacity and as vice president of Compliance and Corporate Secretary, the company added.
- The company said Cogley has had a 15-year career in corporate finance and accounting and recently served as senior manager, Accounting Advisory at CFGI.